Horrell Capital Management’s Biogen BIIB Stock Holding History

Horrell Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-125	Closed	-$53K	–	226
2015 Q1	$53K	Hold	125	–	–	0.02%	176
2014 Q4	$50K	Hold	125	–	–	0.02%	178
2014 Q3	$41K	Hold	125	–	–	0.02%	185
2014 Q2	$39K	Hold	125	–	–	0.02%	196
2014 Q1	$38K	Hold	125	–	–	0.02%	184
2013 Q4	$35K	Hold	125	–	–	0.02%	188
2013 Q3	$30K	Hold	125	–	–	0.02%	186
2013 Q2	$27K	Buy	+125	New	+$26.7K	0.02%	196

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Horrell Capital Management's BIIB Position: Q2 2015 in Review

Horrell Capital Management sold out of Biogen (BIIB) in Q2 2015, closing a stake of 125 shares — an estimated $53K sold.

Horrell Capital Management first reported a position in BIIB in Q2 2013 and held it in 8 quarters. The position peaked at $53K in Q1 2015. 974 funds tracked by Wall St. Rank hold BIIB as of Q2 2015.

Horrell Capital Management reported no remaining Biogen position as of Q2 2015 after selling out during the quarter.
Horrell Capital Management sold 125 Biogen shares in Q2 2015, an estimated $53K.
Horrell Capital Management first reported a position in Biogen in Q2 2013 and held it in 8 quarters.
Horrell Capital Management's Biogen position peaked at $53K in Q1 2015.
974 funds tracked by Wall St. Rank held Biogen as of Q2 2015.

Based on Horrell Capital Management's 13F filing for Q2 2015, filed 21 Jul 2015.